Back to Search Start Over

Recombinant Porcine Interferon-α Decreases Pseudorabies Virus Infection

Authors :
Bowen Song
Wenkang Wei
Xueyi Liu
Yaoyao Huang
Shuaiqi Zhu
Lin Yi
Eerdunfu
Hongxing Ding
Mingqiu Zhao
Jinding Chen
Source :
Vaccines, Vol 11, Iss 10, p 1587 (2023)
Publication Year :
2023
Publisher :
MDPI AG, 2023.

Abstract

Interferon (IFN) is a cell-secreted cytokine possessing biological activities including antiviral functioning, immune regulation, and others. Interferon-alpha (IFN-α) mainly derives from plasmacytoid dendritic cells, which activate natural killer cells and regulate immune responses. IFN-α responds to the primary antiviral mechanism in the innate immune system, which can effectively cure acute infectious diseases. Pseudorabies (PR) is an acute infectious disease caused by pseudorabies virus (PRV). The clinical symptoms of PRV are as follows: reproductive dysfunction among pregnant sows and high mortality rates among piglets. These pose a severe threat to the swine industry. Related studies show that IFN-α has broad applications in preventing and treating viral diseases. Therefore, a PRV mouse model using artificial infection was established in this study to explore the pathogenic effect of IFN-α on PRV. We designed a sequence with IFN-α4 (M28623, Genbank) and cloned it on the lentiviral vector. CHO-K1 cells were infected and identified using WB and RT-PCR; a CHO-K1 cell line with a stable expression of the recombinant protein PoIFN-α was successfully constructed. H&E staining and virus titer detection were used to investigate the recombinant protein PoIFN-α’s effect on PR in BALB/c mice. The results show that the PoIFN-α has a preventive and therapeutic impact on PR. In conclusion, the recombinant protein can alleviate symptoms and reduce the replication of PRV in vivo.

Details

Language :
English
ISSN :
2076393X and 54489431
Volume :
11
Issue :
10
Database :
Directory of Open Access Journals
Journal :
Vaccines
Publication Type :
Academic Journal
Accession number :
edsdoj.976b544894314f119c4074fa30d72c29
Document Type :
article
Full Text :
https://doi.org/10.3390/vaccines11101587